Insurance companies, which often end up on the hook for expenses when a medical device fails, are pursuing legal action to recoup more of the health services costs from manufacturers.
According to a Reuters report, the biggest recalls can lead to billions of dollars in expenses, and medical device makers are already worried about weaker global demand for many of their products and the impact of a new U.S. tax on ...
continue reading...
Johnson & Johnson has agreed to settle five lawsuits in Philadelphia Court of Common Pleas, based on claims that its antipsychotic drug Risperdal caused five boys to grown breast tissue.
Terms of the settlement weren’t disclosed, Bloomberg reports.
The lawsuits are among more than 400 in which J&J and its Janssen unit were accused of injuries caused by Risperdal. More than 100 of those suits involve claims that the drug caused young ...
continue reading...
According to a story posted on Fox News, the U.S. Food and Drug Administration has issued a warning letter to medical device maker Zimmer Holdings Inc., mentioning concerns about the manufacture of certain hip implants.
The letter was sent following an agency inspection of the company’s plant in Puerto Rico, which found manufacturing and testing issues related to the company’s Trilogy Acetabular System products — implanted in hip-replacement surgery.
The report came ...
continue reading...Researchers in the U.K. have recommended that women not receive all-metal hip replacements because of the procedure’s early failure rate, Bloomberg reports.
In a study published in the Lancet medical journal, scientists who analyzed data from the National Joint Registry for England and Wales found that women experience more problems than men in the seven years after surgery. They also found that “metal-on-metal” resurfacing implants fail more quickly than total hip ...
continue reading...
Nonprofit organization Public Citizen reports that state settlements with drug companies over Medicaid fraud are at an all-time high.
The report says many states have recovered just as much, if not more, money from pharmaceutical companies accused of defrauding Medicaid programs as they spent on all Medicaid fraud enforcement. A total of $6.6 billion had been recovered from the beginning of 2012 through mid-July by both the federal government and states, ...
continue reading...The Philadelphia Inquirer reports that lawyers representing pharmaceutical giant Johnson & Johnson successfully quashed a subpoena to compel CEO Alex Gorsky to testify about allegations that inappropriate marketing harmed children taking the company’s drugs.
The case involves a 17-year-old boy whose family sued the company because he grew breasts after taking J&J antipsychotic drug Risperdal.
It’s the second of a string of Risperdal trials. The first one concerned a 21-year-old man prescribed ...
continue reading...
